Global Artificial Tears Market Size and Forecast to 2029: Revenue, Growth, and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial tears market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Artificial Tears Market Size Today And What Will Its Value Be At The End Of 2029?

The artificial tears market has demonstrated significant expansion in recent years. Its value is anticipated to rise from $3.55 billion in 2024 to $3.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.5%. This historical growth can be linked to contributors such as an aging population, increased prolonged screen time, greater healthcare expenditure, a transition from prescription to OTC options, and various regulatory changes.

The artificial tears market is anticipated to experience robust expansion in the coming years. This market is projected to reach $4.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth over the forecast period include the rising incidence of dry eye syndrome, increased contact lens adoption, worldwide urbanization, escalating pollution levels, and the expansion of e-commerce. Key trends during this period encompass technological innovations, the incorporation of AI and other technologies, collaborations with healthcare professionals, the inclusion of natural components, progress in product development, sophisticated drug delivery mechanisms, and the emergence of sustainable and environmentally friendly products.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

Which Key Drivers Are Powering Growth In The Artificial Tears Market?

The increasing occurrence of dry eye disease is projected to boost the expansion of the artificial tear market in the future. Dry eye disease is a condition characterized by insufficient tear production or tears of substandard quality, resulting in irritation and discomfort. Artificial tears serve to augment natural tear production, offering lubrication and soothing relief for dry eyes. For example, data from March 2022, based on a survey of 5,000 respondents conducted by Macquarie University, an Australia-based public research university, indicated that among individuals aged 50 and above, 13% (15 out of 120) displayed clinical indicators of dry eye disease (DED), broken down into 8.2% mild, 2.5% moderate, and 1.6% severe cases. Furthermore, in March 2022, Eyes On Eyecare, a US-based digital ophthalmology news provider, reported an increase in the utilization of prescription and in-office treatments for dry eye disease, climbing from 5.8% in 2021 to 7.56% in 2022. During this period, prescription treatments such as topical steroids notably surged from 0.9% to 9.1%. Consequently, the escalating prevalence of dry eye disease is fueling the expansion of the artificial tear market.

Which Segment Categories Are Driving Maximum Growth In The Artificial Tears Market?

The artificial tears market covered in this report is segmented –

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears

2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray

3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications

4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:

1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears

2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears

3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears

4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears

5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears

6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

What Key Trends Are Driving Growth In The Artificial Tears Market?

Leading companies within the artificial tears market are developing products that integrate technologies, such as patented pureflow technology, with the aim of improving product safety and user experience. Patented pureflow technology represents a specialized dispensing method utilizing a one-way valve to guarantee the sterile delivery of preservative-free eye drops, thereby preventing contamination and preserving the product’s integrity. For instance, in January 2022, Alcon Inc., a medical device and pharmaceutical firm based in Switzerland, introduced Systane Complete Preservative-Free Lubricant Eye Drops. These advanced artificial tears are specifically formulated to ease symptoms associated with all primary forms of dry eye, including evaporative dry eye and aqueous tear deficiency. As a preservative-free solution, they provide up to eight hours of sustained relief by hydrating and shielding every layer of the tear film. Employing nano-droplet technology, the drops supply swift hydration to the eye surface, preventing tear evaporation and delivering rapid, effective comfort. Packaged in a practical multi-dose bottle featuring PureFlow technology, the design ensures safety by inhibiting contamination, making it an ideal choice for frequent users and individuals with sensitive eyes.

Who Are The Leading Companies Driving The Artificial Tears Market?

Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

Which Region Holds The Largest Share In The Artificial Tears Market Today?

North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13799&type=smp

Browse Through More Reports Similar to the Global Artificial Tears Market 2025, By The Business Research Company

Artificial Intelligence Chipsets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence Software As A Service Saas Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-software-as-a-service-saas-global-market-report

Artificial Intelligence In Healthcare Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795